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The presence of concomitant chronic total occlusion in patients with
ischemic heart failure is related with worse long-term outcomes – report
from COMMIT-HF registry.
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BACKGROUND Many reports showed that the presence of concomi-
tant chronic total occlusion (CTO) in a non-culprit lesion in acute
coronary syndromes is associated with impaired prognosis. However,
there is insufﬁcient data evaluating the effect of concomitant CTO in
patients with ischemic systolic heart failure (HF). The aim of our
analysis was to assess the effect of the concomitant CTO on long-term
prognosis in patients with ischemic systolic HF.
METHODS The COMMIT-HF is an ongoing single-center systolic HF
registry (inclusion criteria: HF with LVEF <35%, exclusion: ACS). A
total of 1798 patients were enrolled since 2009. Among them we have
selected a subset of ischemic HF subjects who underwent elective
coronary angiography (n¼675). The patients were divided into two
groups with regard to CTO presence (not protected by a patent
vascular graft). All of the analyzed patients are followed up for a
period of at least 12 months with all-cause mortality deﬁned as pri-
mary endpoint.
RESULTS Baseline patient characteristics are presented in Table 1.
The comparison of echocardiographic parameters and administered
medical treatment showed no signiﬁcant differences. In both groups
around half of subjects had PCI performed (46,7% vs. 56,4%,
p¼0,01). 12-month follow-up revealed signiﬁcantly higher mortality
in the CTO group (19,4% vs 10,3%, p<0,001), evident also after 24
months (26,6% vs. 17,6%, p¼0,01). This was also observed in the
subgroup of pts who underwent PCI (12-month mortality 17,6% vs
9.8%, p¼0,03, 24-month 25,2% vs 18,1%), p¼0,15). Multivariate
analysis revealed that the presence of concomitant CTO was an
independent factor increasing mortality (OR 2,34, 95% CI 1,38-3,96,
p¼0,001).CTO, n[278 Non-CTO, n[397 pSex 236M vs 42F 315M vs 82F 0.06Age 65.410,5 63.910,6 0.07
Mean EF [%] 26.85,5 27.15,9 0.58
Atrial ﬁbrillation [%] 27.7 26.2 0.66NYHA III & IV [%] 44.2 44.3 0.99Chronic kidney disease
stage III-V [%]32.0 30.2 0.68Diabetes [%] 50.0 43.0 0.07Post-CABG [%] 38.0 25.9 0.003Post-MI [%] 76.9 66.2 0.002ICD/CRT-D [%] 64.7 61.4 0.38CONCLUSIONS Our analysis showed that in patients with ischemic
heart failure the presence of the chronic total occlusion is related to
worse long-term outcomes. Therefore, HF patients with concomitant
CTO should always be assessed with regard to the viability of CTO
recanalization.
CATEGORIES STRUCTURAL: Heart Failure
KEYWORDS Chronic total occlusion, Coronary artery disease,
chronic, Heart failure
TCT-736
Hemodynamic Predictors of Renal Dysfunction and Mortality in Left
Ventricular Diastolic Dysfunction and Pulmonary Hypertension
Deepakraj Gajanana,1 Bhaskar Purushottam,2 David Wheeler,1
Sean F. Janzer,3 Dennis L. Morris,1 Vincent M. Figueredo1
1Einstein Medical Center, Philadelphia, PA; 2Mount Sinai School of
Medicine, New York, NY; 3Einstein Medical Center, Philadelphia, PA
BACKGROUND There is limited data on hemodynamic predictors of
renal function in patients with left ventricular diastolic dysfunction
and pulmonary hypertension. Our objective was to analyze the
strength of correlation between standard and novel hemodynamic
indices, including right atrial to pulmonary capillary wedge ratio
(RA:PCWP) and pulmonary artery pulsatility index (PAPi), with renalfunction in patients with diastolic dysfunction {left ventricular ejec-
tion fraction (LVEF) 50%} who had pulmonary hypertension (mean
pulmonary artery pressure >25 mm Hg).
METHODS We retrospectively screened 172 patients with pulmonary
hypertension who underwent a right heart catheterization (RHC) be-
tween 2007 and 2012 at Einstein Medical Center, Philadelphia. A
multivariate logistical regression including standard RHC variables,
pulmonary artery pulse pressure (PAPP), PAPi (PAPP/RA) and
RA:PCWP ratio was used to identify predictors of renal dysfunction
and mortality. Linear regression was used to evaluate PAPi as signif-
icant predictors of length of stay.
RESULTS The ﬁnal cohort consisted of 46 patients, with mean age
60.412.2 years and 78.3% male. Among the standard and novel he-
modynamic indices, only PAPi independently predicted 90-day mor-
tality (OR 0.832, 95% CI 0.703 – 0.985). Patients who died within 90
days (n¼10, 21.7%) had an average lower PAPi than those who sur-
vived (1.930.42 vs 3.560.40, p ¼ 0.05). Patients with PAPi greater
than 2.75 had lower rates of renal dysfunction (deﬁned as worsening
of GFR by greater than 10 mL/min/1.73 m2) at the time of RHC (9.5% vs
28%). Finally, linear regression conﬁrmed that PAPi is negatively
correlated with length of stay (p ¼ 0.013).Variable b P-value OR 95% CIRA 0.51 0.08 1.6 0.92 - 2.9Mean PA -0.01 0.9 0.99 0.85 - 1.15PAPP -0.71 0.21 0.48 0.15 - 1.5PCWP -0.39 0.13 0.67 0.39 - 1.13RA:PCWP -3.4 0.41 0.03 0.1 - 118.4PAPi -0.19 0.03 0.91 0.7 - 0.9Cardiac output 0.31 0.19 1.37 0.85 – 2.2CONCLUSIONS PAPi is a better predictor of length of stay, renal
dysfunction and 90-day mortality than the standard RHC variables in
patients with pulmonary hypertension with preserved ejection
fraction.
CATEGORIES STRUCTURAL: Heart Failure
KEYWORDS Diastolic heart failure, Hemodynamics, Pulmonary hy-
pertension
TCT-737
Less Invasive Transcatheter Ventricular Volume Reduction and Reshaping
for Ischemic Heart Failure
Horst Sievert1
1CardioVascular Center Frankfurt CVC, Frankfurt, Germany
BACKGROUND Despite widespread use of percutaneous coronary
revascularization techniques and short door to balloon times,
myocardial scarring following an acute infarction remains prevalent.
